# A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm Birth

> **NCT02326142** · PHASE2 · TERMINATED · sponsor: **ObsEva SA** · enrollment: 10 (actual)

## Conditions studied

- Preterm Labor

## Interventions

- **DRUG:** OBE001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02326142
- **Lead sponsor:** ObsEva SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2016-10
- **Final completion:** 2017-10
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Enrolment difficulties.
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02326142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02326142, "A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm Birth". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02326142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*